IsUpdate
HasProtocol
IsUpdate
HasProtocol
IsUpdate
HasPlataform http://derma.jmir.org
IsConcluded
LivingReviews:Protocol
LivingReviews:Protocol
conduct a living systematic
NoInTitle
living systematic review
NoInTitle
CENTRAL, Ovid MEDLINE, Ovid Embase, Ovid PsycINFO, EBSCO CINAHL, and Clarivate Web of Science Core Collection
living systematic review
NoInTitle
IsUpdate
HasUpdate
This living systematic review
NoInTitle
IsUpdate
Revisar
CENTRAL, MEDLINE, Embase, ClinicalTrials.gov, and WHO ICTRP
living systematic review
NoInTitle
IsUpdate
Esta no es solo una actualización es una errata, cómo debo tratar esto
LivingReviews:Protocol
https://www.wikidata.org/wiki/Q91945676
LivingReviews:Protocol
Revisar
IsUpdate
As this is a living systematic review
NoInTitle
living systematic review
NoInTitle
a living systematic
NoInTitle
living systematic review
NoInTitle
living systematic review
NoInTitle
LivingReviews:Protocol
IsUpdate
LivingReviews:Protocol
IsUpdate 2021
https://hyp.is/0JC6cIdyEfCS6ks5s2WWJQ/pubmed.ncbi.nlm.nih.gov/32511471/
IsUpdate
IsUpdate
NoClearUpdate
IsUpdate
IsUpdate 2024
IsUpdate
IsUpdate
NoClearUpdate
IsUpdate
IsUpdate
IsUpdate
IsUpdate
NoClearUpdate
HasUpdates
IsUpdate
HasUpdates
Tiene Updates
ToDo
PRISMA checklist
LivingReviews:Protocol
Grading of Recommendations Assessment, Development and Evaluation (GRADE)
LivingReviews:Method
PICO questions
LivingReviews:Method
L·OVE (Living OVerview of Evidence)
LivingReviewsDescubridor
LivingReviews:Protocol
randomised controlled trials (RCTs)
DocumentalType
iving systematic review approach
NoInTitle
LivingReviews:Protocol
LivingReviews:Protocol
Tiene updates?
Escrito en italiano
https://www.recentiprogressi.it/archivio/3565/articoli/35458/
LivingReviews/Plataform https://www.deplazio.net/farmacicovid/
Marcado en https://hyp.is/go?url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F33687358%2F&group=world
_Hypothes.is no reconoce el DOI
Update
NoClearUpdate
Tiene muchas actualizaciones
Update of Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. 189 2 189 0 Similar articles Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4. PMID: 33044747 158 7 56 0 Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Cochrane Database Syst Rev. 2021 May 20;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub4. Update in: Cochrane Database Syst Rev. 2023 Feb 1;2:CD013600. doi: 10.1002/14651858.CD013600.pub5. PMID: 34013969 Free PMC article. 193 4 81 0 Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. 189 2 189 0 Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Cochrane Database Syst Rev. 2021 May 24;5(5):CD015043. doi: 10.1002/14651858.CD015043. PMID: 34029377 Free PMC article. 116 2 88 2 Remdesivir for the treatment of COVID-19. Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD014962. doi: 10.1002/14651858.CD014962. Update in: Cochrane Database Syst Rev. 2023 Jan 25;1:CD014962. doi: 10.1002/14651858.CD014962.pub2. PMID: 34350582 Free PMC article. 209 0 97 2
living systematic review approach
NoInTitle
Update
NoClearUpdate
living systematic review
NoInTitle
LivingReviews:Protocol
Update. ?
LivingReviews/Plataform https://www.safeinpregnancy.org/
Child[MeSH]
Pediatrics
LivingReviews/Plataform http://www.systematicreviewlution.com/
using a living systematic review approach
NoInTitle
LivingReviews/Plataform www.covid19lnma.com
living systematic review approach
NoInTitle
living systematic review
NoInTitle
living systematic review
NoInTitle
We aim to conduct a living systematic review and meta-analysis
NoInTitle
living systematic review
NoInTitle
Update?
LivingReviews:Protocol
controlled studies
DocumentalType
Updates
LivingReviews:Protocol
living systematic review
NoInTitle
Updates
https://pubmed.ncbi.nlm.nih.gov/32648959/ https://pubmed.ncbi.nlm.nih.gov/34013969/ https://pubmed.ncbi.nlm.nih.gov/33044747/
We will update this review as a living systematic review
NoInTitle
LivingReviews:Protocol
Updates
https://doi.org/10.1136/bmj.o1717 2022
Revisar
Studies
DocumentalType
This living systematic review
NoInTitle
Randomised controlled trials (RCTs)
DocumentalType
randomized controlled trials (RCTs) and nonrandomized studies (NRSs)
DocumentalType
This meta-analysis shows that cannabis smoking increased the risk of suicide attempt, suicidal ideation and suicide planning in young individuals of 11-21 years of age. The high risk of suicide behaviors could vary depending on the population studied; therefore, more studies are necessary to corroborate the risk of presenting suicide behaviors in individuals of 11-21 years of age who smoke cannabis.
BIOmetaAnalysis
There is considerable variation in the estimated effect size among included studies due to heterogeneity; hence, a random effect model was used for meta-analysis. The findings of our study suggest that the effect size of BDNF levels was 0.25 with 95% CI (-0.55; 1.05) in cannabis users, which was not statistically significant (p-value=0.54). Therefore, it is important to interpret the results with caution, and additional research is warranted to investigate the potential factors contributing to this heterogeneity.
BIOmetaAnalysis
Estos hallazgos resaltan la necesidad de incluir el consumo de cannabis como factor de riesgo en la planificación quirúrgica y los protocolos de atención al paciente, y se justifica la realización de más estudios.
BIOmetaAnalysis
https://effectivehealthcare.ahrq.gov/products/plant-based-chronic-pain-treatment/living-review
https://effectivehealthcare.ahrq.gov/products/plant-based-chronic-pain-treatment/protocol
20 Updates
40238954 39466982 38683921 38437496 37847805 37769055 37769057 37769056 37769058 36351096 36795908 36795909 36795907 36795906 34882379 34756847 34228409 34228408 33764726
Nota: tiene muchas actualizaciones La última es de 2024
LivingReviews:Protocol
Update
LivingReviews:Protocol
LivingReviews:Protocol
Child[MeSH]
Pediatrics
LivingReviews:Protocol
Child[MeSH]
Pediatrics
LivingReviews:Protocol
Revisar
LivingReviews:Protocol
Pediatrics
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
Dos? Revisar
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol
LivingReviews:Protocol